# Foxy-5 as Neo-Adjuvant Therapy in Subjects With Wnt-5a Low Colon Cancer

> **NCT03883802** · PHASE2 · UNKNOWN · sponsor: **WntResearch AB** · enrollment: 100 (estimated)

## Conditions studied

- Colon Cancer

## Interventions

- **DRUG:** Foxy-5
- **DRUG:** FOLFOX regimen
- **PROCEDURE:** Tumour resection (colon cancer surgery)

## Key facts

- **NCT ID:** NCT03883802
- **Lead sponsor:** WntResearch AB
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-04-12
- **Primary completion:** 2024-12-14
- **Final completion:** 2024-12-14
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2022-12-09

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03883802

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03883802, "Foxy-5 as Neo-Adjuvant Therapy in Subjects With Wnt-5a Low Colon Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03883802. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*